Publication: Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis.
dc.contributor.author | Arias-de la Rosa, Ivan | |
dc.contributor.author | Escudero-Contreras, Alejandro | |
dc.contributor.author | Ruiz-Ponce, Miriam | |
dc.contributor.author | Cuesta-Lopez, Laura | |
dc.contributor.author | Roman-Rodriguez, Cristobal | |
dc.contributor.author | Perez-Sanchez, Carlos | |
dc.contributor.author | Ruiz-Limon, Patricia | |
dc.contributor.author | Ruiz, Rocio Guzman | |
dc.contributor.author | Leiva-Cepas, Fernando | |
dc.contributor.author | Alcaide, Juan | |
dc.contributor.author | Segui, Pedro | |
dc.contributor.author | Plasencia, Chamaida | |
dc.contributor.author | Martinez-Feito, Ana | |
dc.contributor.author | Font, Pilar | |
dc.contributor.author | Abalos, María C | |
dc.contributor.author | Ortega, Rafaela | |
dc.contributor.author | Malagon, Maria M | |
dc.contributor.author | Tinahones, Francisco J | |
dc.contributor.author | Collantes-Estevez, Eduardo | |
dc.contributor.author | Lopez-Pedrera, Chary | |
dc.contributor.author | Barbarroja, Nuria | |
dc.contributor.funder | Consejería de Conocimiento, Investigación y Universidad, Junta de Andalucía | |
dc.contributor.funder | Institute of Health Carlos III, ISCIII | |
dc.contributor.funder | MINECO | |
dc.contributor.funder | Junta de Andalucia (Nicolas Monardes program) | |
dc.contributor.funder | European Regional Development Fund (ERDF) | |
dc.date.accessioned | 2023-05-03T15:02:09Z | |
dc.date.available | 2023-05-03T15:02:09Z | |
dc.date.issued | 2022-08-03 | |
dc.description.abstract | We aimed to evaluate the association between adipose tissue (AT) dysfunction, autoimmunity, and disease activity in rheumatoid arthritis (RA). A cross-sectional study including 150 RA patients and 50 healthy donors and longitudinal study with 122 RA patients treated with anti-tumor necrosis factor (TNF)-α, anti-interleukin 6 receptor (IL6R) or anti-CD20 therapies for 6 months were carried out. In vitro experiments with human AT and adipocyte and macrophage cell lines were performed. A collagen-induced arthritis mouse model was developed. The insulin resistance and the altered adipocytokine profile were associated with disease activity, the presence of anti-citrullinated proteins anti-bodies (ACPAs), and worse response to therapy in RA. AT in the context of arthritis is characterized by an inflammatory state alongside the infiltration of macrophages and B/plasmatic cells, where ACPAs can have a direct impact, inducing inflammation and insulin resistance in macrophages and promoting a defective adipocyte differentiation, partially restored by biologicals. | |
dc.description.sponsorship | We thank all the patients for their kind participation in this study. This research was funded by grants from the Institute of Health Carlos III, ISCIII (PI17/01316, PI20/00079, PI21/005991, and RICOR-RD21/0002/0033), co-financed by the European Regional Development Fund (ERDF), a way to make Europe, Spain, MINECO (RyC-2017-23437), the Andalusian Foundation of Rheumatology (FAR) and Consejerı´a de Conocimiento, Investigación y Universidad, Junta de Andalucı´a (P20_01367). C.L.-P. was supported by a contract from the Junta de Andalucia (Nicolas Monardes program). J.A. was supported by a ‘‘PFIS’’ predoctoral contract (FI19/00177). P.R.L. was supported by a ‘‘Sara Borrell’’ postdoctoral contract (CD19/00216) from the ISCIIIMadrid (Spain), co-financed by the Fondo Europeo de Desarrollo Regional-FEDER. | |
dc.description.version | Si | |
dc.identifier.citation | Arias-de la Rosa I, Escudero-Contreras A, Ruiz-Ponce M, Cuesta-López L, Román-Rodríguez C, Pérez-Sánchez C, et al. Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis. iScience. 2022 Aug 6;25(9):104893 | |
dc.identifier.doi | 10.1016/j.isci.2022.104893 | |
dc.identifier.essn | 2589-0042 | |
dc.identifier.pmc | PMC9421387 | |
dc.identifier.pmid | 36046189 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421387/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.isci.2022.104893 | |
dc.identifier.uri | http://hdl.handle.net/10668/22278 | |
dc.issue.number | 9 | |
dc.journal.title | iScience | |
dc.journal.titleabbreviation | iScience | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.organization | Instituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC | |
dc.organization | Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO | |
dc.organization | Hospital Universitario Virgen de la Victoria | |
dc.organization | Instituto de Investigación Biomédica de Málaga-IBIMA | |
dc.page.number | 22 | |
dc.provenance | Realizada la curación de contenido 09/08/2024 | |
dc.publisher | Cell Press | |
dc.pubmedtype | Journal Article | |
dc.relation.projectID | P20_01367 | |
dc.relation.projectID | PI17/01316 | |
dc.relation.projectID | RyC-2017-23437 | |
dc.relation.projectID | FI19/00177 | |
dc.relation.projectID | RICOR-RD21/0002/0033 | |
dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S2589-0042(22)01165-8 | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Health sciences | |
dc.subject | Immunology | |
dc.subject | Rheumatology | |
dc.subject.mesh | Arthritis, experimental | |
dc.subject.mesh | Cross-sectional studies | |
dc.subject.mesh | Autoimmunity | |
dc.subject.mesh | Biological products | |
dc.subject.mesh | Insulin resistance | |
dc.subject.mesh | Arthritis, rheumatoid | |
dc.subject.mesh | Adipocytes | |
dc.title | Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 25 | |
dspace.entity.type | Publication |
Collections
Centro Pfizer-Andalucía de Genómica e Investigación Oncológica (GENYO)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario Virgen de la Victoria
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario Virgen de la Victoria